Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy

Lymphoma Clinical Trial

Official title:

Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01078350
• Other study ID #: BANKPEDSTS0001
• Secondary ID: 80003SU-11052007
• Status: Completed
• Phase: N/A
• First received: February 26, 2010
• Last updated: November 16, 2017
• Start date: May 2004
• Est. completion date: December 4, 2015

Study information

• Verified date: November 2017
• Source: Stanford University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study is designed to collect tissue samples that may aid in the treatment and learning about various oncology diagnosis.

Description:

The purpose of this study is to provide a mechanism to obtain tissue specimens to be used for experimental studies before the exact histologic diagnosis is known.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 93
• Est. completion date: December 4, 2015
• Est. primary completion date: December 4, 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 21 Years

Eligibility

Inclusion Criteria:

• Subjects who are having a tissue procedure done as part of their standard oncology work-up will be eligible to be consented on this study.

Exclusion Criteria:

Related Conditions & MeSH terms

• Hodgkin Disease
• Lymphoma

Intervention

Procedure:
• tumor tissue aspiration

• phlebotomy

Locations

Country	Name	City	State
United States	Stanford University School of Medicine	Stanford	California

Sponsors (1)

Lead Sponsor	Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Further analysis		at collection time